Supplier

GILEAD SCIENCES SL

Value won

€7.7m

Across 7 contracts won

A Spain supplier, with 7 awarded contracts, most recently 8 months ago.

Spain(inferred)

Value won

€7.7m

Across 7 contracts won

Contract history

7 entries

Most recent
25 Feb 2026
8 months ago
Biggest
€7.7m
Supply of Sofosbuvir and Associated…
Average size
€7.7m
Across 1 priced
Last 12 months
3
entries

Won · 7

Supply of Axicabtagen Ciloleucel MedicationValue not disclosed · 25 Feb 2026 Supply of Axicabtagen Ciloleucel MedicationValue not disclosed · 24 Feb 2026 Supply of Axicabtagen Ciloleucel for Health Services in VigoValue not disclosed · 9 Nov 2025 Supply of Axicabtagen Ciloleucel MedicationValue not disclosed · 13 Oct 2025 Supply of Sofosbuvir and Associated Medicines€7,722,035 · 10 Jul 2025 Supply of Axicabtagen Ciloleucel for Health Services in VigoValue not disclosed · 19 May 2025 Supply of Axicabtagen Ciloleucel for Health Services in VigoValue not disclosed · 5 May 2025

Apr 25Jul 25Sept 25Dec 25Mar 26

Opportunities

Showing awarded · 7

AwardedHealthcare & MedicalSpain

Supply of Axicabtagen Ciloleucel Medication

This contract involves the ongoing supply of the medication Axicabtagen Ciloleucel for the Health Area of A Coruña and Cee. The contract is awarded based on a framework agreement and is intended to ensure that this essential medication is available for patients in need. Suppliers interested in this

CORUA AND CEE HEALTH AREA GALICIAN HEALTH SERVICE

Published 25 Feb 2026

AwardedHealthcare & MedicalSpain

Supply of Axicabtagen Ciloleucel Medication

This contract is for the ongoing supply of the medication "Axicabtagen Ciloleucel" under a framework agreement. The contract is awarded to support the Health Area of A Coruña and Cee, ensuring that healthcare providers have access to this essential treatment. Suppliers interested in this opportunity

CORUA AND CEE HEALTH AREA GALICIAN HEALTH SERVICE

Published 24 Feb 2026

AwardedHealthcare & MedicalSpain

Supply of Axicabtagen Ciloleucel for Health Services in Vigo

This contract involves the ongoing supply of the medication Axicabtagen Ciloleucel, awarded as the thirteenth contract under a framework agreement. The contract is specifically for the Health Area of Vigo, managed by the Galician Health Service (Servizo Galego de Saúde). Suppliers are invited to pro

GALICIAN HEALTH SERVICE VIGO HEALTH AREA

Published 9 Nov 2025

AwardedHealthcare & MedicalSpain

Supply of Axicabtagen Ciloleucel Medication

This contract is awarded for the ongoing supply of the medication "Axicabtagen Ciloleucel" under the Framework Agreement for the Health Area of A Coruña and Cee. Suppliers are invited to provide this specific antineoplastic agent, which is crucial for cancer treatment. The contract is managed by the

CORUA AND CEE HEALTH AREA GALICIAN HEALTH SERVICE

Published 13 Oct 2025

AwardedHealthcare & MedicalSpain

Supply of Sofosbuvir and Associated Medicines

This contract involves the supply of Sofosbuvir, along with its combinations with Velpatasvir and Voxilaprevir. The procurement is aimed at ensuring the availability of these essential pharmaceutical products for healthcare services. Suppliers are invited to provide these medications, which are crit

€7,722,035OSAKIDETZA BASQUE HEALTH SERVICE CENTRAL ORGANIZATION

Published 10 Jul 2025

AwardedHealthcare & MedicalSpain

Supply of Axicabtagen Ciloleucel for Health Services in Vigo

This contract involves the ongoing supply of the medication Axicabtagen Ciloleucel, awarded under a framework agreement. It is intended for the Health Area of Vigo, managed by the Servizo Galego de Saúde. Suppliers are invited to provide this specific antineoplastic agent, which is crucial for cance

GALICIAN HEALTH SERVICE VIGO HEALTH AREA

Published 19 May 2025

AwardedHealthcare & MedicalSpain

Supply of Axicabtagen Ciloleucel for Health Services in Vigo

This contract involves the ongoing supply of the medication Axicabtagen Ciloleucel, awarded under a framework agreement. It is intended for the Health Area of Vigo, managed by the Galician Health Service. Suppliers are invited to provide this specific antineoplastic agent, which is crucial for cance

GALICIAN HEALTH SERVICE VIGO HEALTH AREA

Published 5 May 2025